Conference Presentation Schedules, Approvals, Regulatory Updates, and Awards - Analyst Notes on St. Jude Medical, Waters, Hologic, Orexigen and USANA

NEW YORK, June 10, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding St. Jude Medical, Inc. (NYSE: STJ), Waters Corporation (NYSE: WAT), Hologic, Inc. (NASDAQ: HOLX), Orexigen Therapeutics, Inc. (NASDAQ: OREX) and USANA Health Sciences, Inc. (NYSE: USNA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3549-100free.

St. Jude Medical, Inc. Analyst Notes
On June 4, 2014, St. Jude Medical, Inc. (St. Jude Medical) announced that its senior management will present at two upcoming conferences. According to the Company, its Group President, Eric Fain, will present at the Goldman Sachs 35th Annual Global Healthcare Conference on June 11, 2014, at 8:40 a.m. PT, at Rancho Palos Verdes, California; while CFO, Don Zurbay, is scheduled to present at the 2014 Wells Fargo Healthcare Conference on June 17, 2014, at 8:15 a.m. ET, in Boston. St. Jude Medical stated that live webcasts of the presentations, along with replays will be archived and available on the Company's website after the respective conferences for 90 days. The full analyst notes on St. Jude Medical are available to download free of charge at:

http://www.analystsreview.com/Jun-10-2014/STJ/report.pdf

Waters Corporation Analyst Notes
On June 5, 2014, Waters Corporation (Waters) announced that the Chinese Food and Drug Administration (CFDA) approved the registration of the ACQUITY UPLC® TQD system for legal promotion and sale in China as a medical device for routine diagnostic applications and neonatal metabolites diseases screening. Waters stated that the ACQUITY UPLC® TQD system is an UltraPerformance LC®/tandem quadrupole mass spectrometry (UPLC®/MS/MS) system, which is a benchtop, ultra-compact, tandem-quadrupole, mass detector-based system designed for routine UPLC/MS/MS analyses and quantitative applications that features high levels of MS selectivity, robustness, speed, and accuracy. According to the Company, this registration represents the second Waters' mass spectrometer approved for in vitro diagnostic (IVD) applications in China. The full analyst notes on Waters are available to download free of charge at:

http://www.analystsreview.com/Jun-10-2014/WAT/report.pdf

Hologic, Inc. Analyst Notes
On June 4, 2014, Hologic, Inc. (Hologic) announced that its President and CEO, Stephen MacMillan, will present at the Goldman Sachs 35th Annual Global Healthcare Conference on June 11, 2014, at 4:20 p.m. ET, in Rancho Palos Verdes, California. According to the Company, the live audio webcast of the presentation can be accessed through its website on the investor section. A replay of the same can also be accessed through the said location after the conference. The full analyst notes on Hologic are available to download free of charge at:

http://www.analystsreview.com/Jun-10-2014/HOLX/report.pdf

Orexigen Therapeutics, Inc. Analyst Notes
On June 2, 2014, Orexigen Therapeutics, Inc. (Orexigen) announced that the FDA has informed the Company that it plans to reassign the Prescription Drug User Fee Act (PDUFA) action date for the NB32 New Drug Application to June 11, 2014, a day later than the original assignment. The Company reported that the change in date was due to an inadvertent administrative error that led the Agency to miscalculate the originally assigned PDUFA date. The full analyst notes on Orexigen are available to download free of charge at:

http://www.analystsreview.com/Jun-10-2014/OREX/report.pdf

USANA Health Sciences, Inc. Analyst Notes
On June 5, 2014, USANA Health Sciences, Inc. (USANA) announced that it has been awarded with five Best of State medals and The Best of State Statue (BOSS®) for its innovative science and exceptional nutritional supplements, personal care, and energy products. The Company stated that since 2003, USANA has earned 33 Best of State awards including three BOSS® statues, and 2014 is the eleventh year that USANA has been recognized to have the best dietary supplements in the state and the fourth year for its health and nutrition products. Dan Macuga, Chief Communications Officer and Executive Vice President of Field Development for the Americas said, "To receive recognition from the Best of State time and time again is a tremendous honor. In a state that houses more than 100 dietary supplement manufacturers, it's a true testament to the quality of our products and the science that goes into creating them." The full analyst notes on USANA are available to download free of charge at:

http://www.analystsreview.com/Jun-10-2014/USNA/report.pdf

About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.

EDITOR'S NOTES:

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED